UBS Group’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.31M Buy
455,406
+179,789
+65% +$2.09M ﹤0.01% 3010
2025
Q1
$2.05M Sell
275,617
-121,641
-31% -$904K ﹤0.01% 3683
2024
Q4
$2.38M Buy
397,258
+324,107
+443% +$1.94M ﹤0.01% 3586
2024
Q3
$375K Buy
73,151
+16,520
+29% +$84.6K ﹤0.01% 4288
2024
Q2
$205K Sell
56,631
-86,984
-61% -$315K ﹤0.01% 4532
2024
Q1
$461K Buy
143,615
+11,095
+8% +$35.6K ﹤0.01% 4159
2023
Q4
$649K Buy
132,520
+42,202
+47% +$207K ﹤0.01% 3772
2023
Q3
$492K Sell
90,318
-12,023
-12% -$65.5K ﹤0.01% 3611
2023
Q2
$687K Buy
102,341
+15,483
+18% +$104K ﹤0.01% 3574
2023
Q1
$767K Buy
86,858
+24,722
+40% +$218K ﹤0.01% 3387
2022
Q4
$475K Buy
62,136
+35,131
+130% +$268K ﹤0.01% 3744
2022
Q3
$193K Buy
27,005
+1,725
+7% +$12.3K ﹤0.01% 4084
2022
Q2
$205K Sell
25,280
-24,372
-49% -$198K ﹤0.01% 3916
2022
Q1
$690K Buy
49,652
+50
+0.1% +$695 ﹤0.01% 3540
2021
Q4
$1.39M Sell
49,602
-2,456
-5% -$68.9K ﹤0.01% 3178
2021
Q3
$1.77M Buy
52,058
+36,761
+240% +$1.25M ﹤0.01% 2830
2021
Q2
$625K Sell
15,297
-6,684
-30% -$273K ﹤0.01% 3593
2021
Q1
$885K Sell
21,981
-986
-4% -$39.7K ﹤0.01% 3478
2020
Q4
$1.36M Sell
22,967
-3,711
-14% -$219K ﹤0.01% 2928
2020
Q3
$1.3M Buy
26,678
+3,666
+16% +$178K ﹤0.01% 2755
2020
Q2
$1.11M Sell
23,012
-3,706
-14% -$179K ﹤0.01% 2740
2020
Q1
$742K Buy
26,718
+16,788
+169% +$466K ﹤0.01% 2899
2019
Q4
$297K Sell
9,930
-2,211
-18% -$66.1K ﹤0.01% 4318
2019
Q3
$375K Buy
+12,141
New +$375K ﹤0.01% 3925